Home

Acolo datorie Construi pe puma biotechnology inc Tweet timid rezistență

Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock

Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Profit Outlook
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Profit Outlook

Form 8-K PUMA BIOTECHNOLOGY, INC. For: Jan 13
Form 8-K PUMA BIOTECHNOLOGY, INC. For: Jan 13

Puma Biotechnology Inc (PBYI) Stock 5 Years History [Returns & Performance]
Puma Biotechnology Inc (PBYI) Stock 5 Years History [Returns & Performance]

Articles with Puma Biotechnology
Articles with Puma Biotechnology

Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer

Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat

Puma Biotechnology (PBYI) Company Information - Simply Wall St
Puma Biotechnology (PBYI) Company Information - Simply Wall St

Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters

Puma Biotechnology, Inc.Analytics - Traffic, Statistics and Competitor tracking | WatchMyCompetitor
Puma Biotechnology, Inc.Analytics - Traffic, Statistics and Competitor tracking | WatchMyCompetitor

PBYI Insider Trading - PUMA BIOTECHNOLOGY Inc - SecForm4.Com
PBYI Insider Trading - PUMA BIOTECHNOLOGY Inc - SecForm4.Com

Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Announces $10 Million Private Placement | Business Wire

Puma Biotechnology
Puma Biotechnology

Puma Biotechnology, Inc. 2021 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2021 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz

Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire

Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive

Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2020 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha

Is Puma Biotechnology Inc. late reporting EU clinical trials?
Is Puma Biotechnology Inc. late reporting EU clinical trials?

Do Analysts Expect Puma Biotechnology Inc (PBYI) Stock to Rise After It Is Down -3.83% in a Month?
Do Analysts Expect Puma Biotechnology Inc (PBYI) Stock to Rise After It Is Down -3.83% in a Month?

PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence

Puma Biotechnology
Puma Biotechnology

Puma Biotechnology
Puma Biotechnology

Exhibitor Puma Biotechnology 07-10 - Scripps CME Connection
Exhibitor Puma Biotechnology 07-10 - Scripps CME Connection

Puma Biotechnology
Puma Biotechnology

Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Announces $10 Million Private Placement | Business Wire

Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting